Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Accenture
Johnson and Johnson
Colorcon
Moodys
Daiichi Sankyo
Fish and Richardson
Harvard Business School
US Department of Justice
US Army

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202493

« Back to Dashboard

NDA 202493 describes CHLOROTHIAZIDE SODIUM, which is a drug marketed by Fresenius Kabi Usa, Luitpold, Mylan Institutional, Sagent Pharms, and Sun Pharma Global, and is included in five NDAs. It is available from four suppliers. Additional details are available on the CHLOROTHIAZIDE SODIUM profile page.

The generic ingredient in CHLOROTHIAZIDE SODIUM is chlorothiazide sodium. There are forty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.
Summary for 202493
Tradename:CHLOROTHIAZIDE SODIUM
Applicant:Mylan Institutional
Ingredient:chlorothiazide sodium
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 202493
Ingredient-typeThiazides
Physiological EffectIncreased Diuresis
Suppliers and Packaging for NDA: 202493
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 202493 ANDA Mylan Institutional LLC 67457-263 67457-263-30 1 VIAL in 1 CARTON (67457-263-30) > 18 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Jun 18, 2014TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
QuintilesIMS
AstraZeneca
Citi
US Army
Fish and Richardson
Cipla
Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot